Goose a specialist Pharmaceutical business re-engineering solutions provider, has come out with an Active Pharmaceutical Ingredient (API) Manager.

Goose API Manager is designed for better control and efficiency, ensuring successful completion of projects on time, thereby saves both time and money for Pharmaceutical companies. Another key feature of ‘Goose API Manager’ is sequencing and synchronization of multiple project management activities which is the key to the success of enterprise wide, large scale project management right from initiation stage to Drug Master Filing Process. It gives clear visibility of action points related to a project in terms of completion time, reasons for delay and when it could be completed.

It  meets cGMP guidelines and enables Pharmaceutical companies to connect crucial project management practices maximising business value, communicate project objectives more effectively internally or with third party partners that include systematic treatment of data as well as provide effective technology transfer into the first site of commercial active pharmaceutical ingredient (API) manufacture. Further the solution is an essential component of any Quality by Design initiative, providing the necessary automation, integration and database reporting functionality that ensures all multi-variety data are tracked and measured.

The areas that are likely to witness quantum performance leaps using ‘Goose API Manager’ will be in the 5 phases of API Project Management that include project initiation, feasibility, optimization, validation and Drug Master filing process, also their integration.

The configurable solution is the only one of its kind globally, which enables pharmaceutical companies manage complex projects and improve project delivery quality, yield and significantly bring down the cost of project management.

In  an environment of extreme cost containment, a well-integrated Project Management solution contributes significantly to pharmaceutical business that require product quality enhancements and compliance with strict regulations, as well as improved efficiencies which can lead to reduced costs, stated Deb Pattnaik, CEO, Goose.

Goose has been able to rapidly introduce new pharmaceutical industry solutions to meet growing market demands by leveraging its Pharmaceutical Re-engineering expertise having worked closely with a number of big pharmaceutical companies offering regulatory compliance and enterprise management solutions.

Laurus Labs is one of the leading names in API manufacturing in India with multiple manufacturing sites and capabilities in a wide range of areas including high potent molecules.

“We have implemented Goose Task Manager as an enterprise solution. Currently, it is being used in the organization in areas of Project Management, R&D and Contract Research in collaboration with various functions and departments,” said Dr Satyanarayana, CE, Laurus Labs.

With acknowledgement of its product potential from market leaders such as Laurus Labs, Goose is confident of adding up more enterprise customers in its ‘API Manager’ portfolio.”Our goal is to become an industry standard when it comes to API Project Management,” Deb added.